Plenary Highlights

The SuperFreakonomics of IP Licensing – Do Patents Slow Innovation? - Steven Levitt, co-author of the New York Times best-seller Freakonomics: A Rogue Economist Explores the Hidden Side of Everything and its recent follow-up SuperFreakonomics, will present a keynote address on the unintended impact of the patent system on innovation. He will also discuss his groundbreaking research on the effects of incentives on economics and market behavior as they relate to innovation. A book signing will follow Mr. Levitt’s presentation.  You can buy SuperFreakonomics: Global Cooling, Patriotic Prostitutes, and Why Suicide Bombers Should Buy Life Insurance by Steven D. Levitt and Stephen J. Dubner via Amazon.

Is the U.S. Patent System Under Siege: Congress, the PTO, the FTC and the Supreme Court -The Honorable Judge Paul Michel, retired Chief Judge of the United States Court of Appeals for the Federal Circuit will look at the many challenges facing the U.S. patent system including the reform legislation currently pending in Congress, the USPTO’s efforts to reduce backlogs and improve the quality of issued patents, and increased scrutiny by the Supreme Court and FTC.

IP as a National Responsibility: A Global Outlook for Strategies, Policies and Laws — Economist and Former Vice Presidential Candidate Pat Choate, will join John Whealan, Associate Dean of Intellectual Property Law at George Washington University Law School and Suzanne Michel, Deputy Director of FTC’s Office of Policy Planning to discuss how the United States, Europe, Asia and developing countries might leverage IP to secure future wealth and what this could mean for commercial collaboration across national boundaries.

IP100 Recap: IP Hot Topics 2010 — Over the course of 2010, LES has hosted innovative IP100 forums comprised of high-level IP leaders who have analyzed several hot IP topics. This panel will revisit the topics, review previous findings and discuss what we’ve learned from the world-class IP100 panels about best practices in licensing. Key ‘take-aways’ will be included in a white paper available after the meeting for attendees.

Register now here and save!  Rates increase $100 on September 1^st.

Related posts:

1. BIO IPCC Meeting Starts Off With Some Advice From Circuit Judge Michel BIO’s Intellectual Property Counsel Committee is holding its Fall Conference...
2. BioOhio Annual Conference Goes On The Road For 2010 BioOhio Annual Conference “Innovation Road Show” This year BioOhio has...
3. Biotechnology and Chemical Pharmaceutical Customer Partnership Meeting The next quarterly meeting of the U.S. Patent and Trademark...

Related posts brought to you by Yet Another Related Posts Plugin.

The 8th Annual Pharmaceutical-Biotech Partnering Conference

There are a lot of pharmaceutical and biotechnology investment conferences and Pharma-Biotech networking events in the market.  BioNetwork is offering a conference that offers you the chance to spend quality time with the right people.

With its intimate setting and extensive networking opportunities, you will meet executives from both the Pharmaceutical and Biotech companies who are actively looking for partners to fuel pipelines and find the next cure…and not just attending the event because they have to.

What Makes BioNetwork Different?

Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry

* BMS and Allergan
* Merck and Schering-Plough
* Sanofi-Aventis and Intelliject
* J&J and Takeda
* Eli Lilly and Kowa Pharmaceuticals
* Eli Lilly and Incyte Corporation

The Perfect Pitch: Biotech Investment Challenge

In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early stages or mid-late stages) to a panel of big Pharma executives, VCs, and Investment Banks who are all willing to give their feedback about the strength of your pitch, highlighting portions of the presentations that piqued their interest. This gives the presenting companies, as well as the audience, important insights into what sparks the interest of potential partners and investors. Find out how you can participate.

Onsite Facebook and Onsite Message Board

Tired of sifting through a sea of name tags to find the person you want to meet? Upon check-in, the BioNetwork team will be taking photos of all speakers and attendees so that you can easily spot the person you wish to network with. Then placed in a central location by the registration area, the onsite message board allows you to leave notes for speakers or attendees that you are looking to connect with while at BioNetwork West.

Improved One-To-One Partnering Software

On this website you will find a list of registered attendees along with their contact details (viewable at their discretion), a brief description of their companies and partnership aspirations and a timetable of available meeting rooms. Upon receiving an accepted invitation from a potential partner, you will be able to schedule a private partnering room. It’s easy to use and our team is always available to help you maximize the tool to plan meetings before you even arrive at the event.

Who:  Speakers include:

• Robert Wills, Vice President Alliance Management, Pharmaceuticals Group. Johnson & Johnson
• Jack Tupman, VP Corporate Business Development, Eli Lilly and Company
• Laura Pierce, Vice President, Alliance Management, Bayer Healthcare Pharmaceuticals
• Martin Reeves, VP Business Development, Cephalon

When: 25-27 October, 2010

Where: The Ritz Carlton, Laguna Nigel, CA

Email: bionetwork@wbresearch.com

Visit: BioNetwork West

*Update!!!   BioNetwork has just offered a a 25% discount to PatentBaristas.com readers.  You can get the discount by registering using code 10386XZ299.  Below is the link to the registration page:

Discount code 10386XZ299

Related posts:

1. BioOhio Annual Conference Goes On The Road For 2010 BioOhio Annual Conference “Innovation Road Show” This year BioOhio has...
2. BioPatent Design Conference 2010: Munich, Germany BioPatent Design2010 Building a Robust, Secure Biological Patent to Ensure...
3. Legal Conference Directors Job opening from American Conference Institute: Legal Conference Directors Are...

Related posts brought to you by Yet Another Related Posts Plugin.

This year BioOhio has decided to take its annual conference networking and learning experience around the state.  At each 1-day event, the focus will be on innovation… defining it, discussing it, debating it, and understanding how essential  it is from R&D through commercialization to market.

For 2010, one event becomes three across the state:

NE Ohio on Sept. 28 (Embassy Suites Cleveland-Rockside)

Central Ohio on Oct. 28 (OCLC Conference Center in Dublin)

SW Ohio on Nov. 17 (The Manor House in Mason)

Full agenda details are still being cooked, but some of the major speakers they’ve set up include:

In Cleveland/Independence in September: Frank Douglas, President & CEO, Austen BioInnovation Institute in Akron and Jay Mazelsky, Senior Vice President, Philips Healthcare

In Dublin in October: Christine Poon, Dean of Ohio State University’s Fisher College of Business, and former Worldwide Chairman of Medicines & Nutritionals of J&J

In Mason in November: Thomas Fogarty, MD, Vascular Surgery Pioneer, Inventor, Professor, and Cincinnati native

According to BioOhio spokesman Matt Schutte:

We think this regional-one-year, central-the-next approach will allow us to extend the value of the annual conference and allow more “first timers” to experience the event and learn more about Ohio’s growing bioscience industry.

For registration, click here.

Early bird rates: $55 for members, $90 for non-members, $45 for students

Each event will kick off around 10, include a great lunch, wrap-up around 4:30, and then capped off with a networking reception.  In 2011, they’ll come back to one central event… and if they like how this year goes, they’ll return to the “road show” in 2012.

Related posts:

1. BioPatent Design Conference 2010: Munich, Germany BioPatent Design2010 Building a Robust, Secure Biological Patent to Ensure...
2. Spy v. Spy: BIO’s Intellectual Property Counsel Committee Conference BIO’s Intellectual Property Counsel Committee is holding its Fall Conference...
3. Bioscience Event for Innovators and IP Professionals Event: CincyBio 2009.  The Bioscience Event for Innovators and IP...

Related posts brought to you by Yet Another Related Posts Plugin.

Building a Robust, Secure Biological Patent to Ensure First Time Approval, Protect Product Revenue and Prevent Incoming Attack

The area of BioPatent Design is rapidly evolving, with new developments sparking the Gene debate, developments in Biosimilars, protection issues with regards to DNA sequencing patents, vaccines and stem cells as well as new guidelines issued from the EPO. This is a critical time to make the correct patent drafting decisions! Pharma IQ’s BioPatent Design offers you the perfect gathering to find your solutions.

Who will be speaking at BioPatent Design 2010?

• Andre Bourgouin, VP, Intellectual Property, Ipsen
• Rob Aerts, Principal Patent Attorney, Abbott Healthcare Products B.V.
• Ian Bryan, IP Counsel, GE Healthcare
• Vineet Kohli, Senior Patent Attorney, Merck
• John Beatty, Patent Procedures Management, European Patent Office
• Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA
• Lawrence Cullen, Deputy Director, IPO
• Dr Scott Alban, Head of IP, MedImmune
• Allen Norris, Vice President, Head Group IP, UCB Pharma SA
• Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG
• Morten Rosted, Head of Department, DK Patents, Corporate Patents & Trademarks, H. Lundbeck A/S
• Tim Gaul, Associate General Counsel, Amgen
• David Kappos, Director, IP Group, USPTO
• Martin Sperrle, VP and CIPO, Cytos Biotechnology
• Frank Landolt, Intellectual Property and Legal Counsel, Albynx

When: 07 – 09 September, 2010

Where: Maritim Hotel, Munich, Germany

Email: enquire@iqpc.co.uk

Visit: www.biopatentdesign.com

Related posts:

1. FDA and Xavier University Host Global Outsourcing Conference The FDA and Xavier University have co-developed the first annual...
2. Small Business Patent Data Collection Act of 2010 Sen. Mary Landrieu (D-LA) is Chairwoman of the Senate Small...
3. Nominations Open for the 2010 IP Hall of Fame The nomination process for the 2010 inductees into the IP...

Related posts brought to you by Yet Another Related Posts Plugin.

The Chisum Patent Academy will offer its second annual Intensive Patent Law Training Workshop at its offices in Seattle, Washington, on July 29-31, 2010. The workshop will focus on substantive patent law (patentability and enforcement) through analysis of critical Federal Circuit and Supreme Court decisions.  New material for the 2010 class will likely include business method patentability post-Bilski, written description requirement compliance post-Ariad, and the evolving landscape of inequitable conduct as reflected by the Federal Circuit’s recent grant of rehearing en banc in Therasense (see 2009 syllabus here).

The workshop is team-taught in seminar style (maximum of 10 students) by Donald Chisum, author of the treatise Chisum on Patents (LexisNexis), and Professor Janice Mueller, author of Patent Law, 3d Edition (Aspen 2009). Chisum and Mueller have a combined total of over 40 years experience teaching patent law. The workshop’s coverage is geared for junior patent attorneys, summer associates, engineers, scientists, paralegals, information specialists, and attorneys experienced in non-patent fields who desire an intensive introduction to patent law. Eighteen hours of CLE credit have been applied for.

For registration details, see here.

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.